Innospec Inc. (NASDAQ:IOSP) Shares Sold by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP reduced its stake in shares of Innospec Inc. (NASDAQ:IOSP - Free Report) by 0.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,188,025 shares of the specialty chemicals company's stock after selling 10,939 shares during the quarter. Dimensional Fund Advisors LP owned about 4.76% of Innospec worth $146,828,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Inspire Advisors LLC increased its position in shares of Innospec by 1.6% during the second quarter. Inspire Advisors LLC now owns 6,819 shares of the specialty chemicals company's stock worth $843,000 after purchasing an additional 110 shares in the last quarter. Oppenheimer Asset Management Inc. increased its position in Innospec by 31.4% during the second quarter. Oppenheimer Asset Management Inc. now owns 20,136 shares of the specialty chemicals company's stock worth $2,489,000 after buying an additional 4,812 shares during the period. BOKF NA purchased a new stake in Innospec in the second quarter valued at approximately $329,000. Bahl & Gaynor Inc. boosted its holdings in shares of Innospec by 4.0% in the second quarter. Bahl & Gaynor Inc. now owns 37,618 shares of the specialty chemicals company's stock valued at $4,649,000 after acquiring an additional 1,457 shares during the period. Finally, Texas Permanent School Fund Corp grew its position in shares of Innospec by 0.6% during the second quarter. Texas Permanent School Fund Corp now owns 21,891 shares of the specialty chemicals company's stock worth $2,706,000 after acquiring an additional 129 shares during the last quarter. 96.64% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Innospec news, CFO Ian Cleminson sold 3,398 shares of the business's stock in a transaction on Monday, August 26th. The shares were sold at an average price of $114.74, for a total transaction of $389,886.52. Following the sale, the chief financial officer now directly owns 12,996 shares in the company, valued at approximately $1,491,161.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.52% of the stock is currently owned by company insiders.

Innospec Price Performance

Shares of NASDAQ IOSP opened at $111.94 on Friday. The company has a market cap of $2.79 billion, a PE ratio of 19.01 and a beta of 1.08. The stock has a fifty day moving average price of $115.79 and a 200 day moving average price of $121.78. Innospec Inc. has a 1-year low of $95.69 and a 1-year high of $133.71.

Innospec (NASDAQ:IOSP - Get Free Report) last released its earnings results on Tuesday, August 6th. The specialty chemicals company reported $1.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.02. The company had revenue of $435.00 million for the quarter, compared to analysts' expectations of $468.73 million. Innospec had a return on equity of 14.15% and a net margin of 7.90%. The firm's quarterly revenue was down 9.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.28 EPS. Analysts anticipate that Innospec Inc. will post 5.95 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut shares of Innospec from a "strong-buy" rating to a "buy" rating in a research note on Thursday, August 8th.

View Our Latest Stock Analysis on IOSP

Innospec Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

Read More

• Five stocks we like better than Innospec
• Airline Stocks - Top Airline Stocks to Buy Now
• Take Advantage of Village Farms Stock as Cannabis Market Evolves
• How Technical Indicators Can Help You Find Oversold Stocks
• MarketBeat Week in Review – 9/16 - 9/20
• What Investors Need to Know About Upcoming IPOs
• Don’t Miss These 3 Retail Stocks for Fall Gains

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ Trump’s weapon lurks in abandoned America (From Porter & Company) (Ad)

Should you invest $1,000 in Innospec right now?

Before you consider Innospec, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.

While Innospec currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here